J. Knop

发表

Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells.

I. Bellinghausen, J. Saloga, J. Knop, 1999, The Journal of allergy and clinical immunology.

Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.

T. Tüting, J. Steitz, J. Brück, 2001, Cancer research.

Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

A. Enk, G. Schuler, K. Steinbrink, 1999, Blood.

Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells.

A. Enk, I. Bellinghausen, J. Saloga, 2001, The Journal of allergy and clinical immunology.

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

A. Enk, T. Tüting, K. Steinbrink, 2000, Gene Therapy.

Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells.

A. Enk, K. Wiedemann, H. Jonuleit, 1997, Journal of immunology.

Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner

J. Knop, T. Hultsch, R. Schopf, 1998, Archives of Dermatological Research.

Induction of hapten-specific tolerance by interleukin 10 in vivo

A. Enk, M. Mohamadzadeh, J. Saloga, 1994, The Journal of experimental medicine.

Mycophenolate is effective in the treatment of pemphigus vulgaris.

J. Knop, A. Enk, J. Knop, 1999, Archives of dermatology.

Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation.

A. Enk, F. Matsumura, M. Bros, 2000, The Journal of investigative dermatology.

Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases

J. Knop, G. Müller, A. Enk, 2000, Gene Therapy.

Inhibition of human allergic T‐helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin‐10‐treated dendritic cells and transforming growth factor‐β for their induction

I. Bellinghausen, J. Saloga, J. Knop, 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers.

J. Saloga, H. Jonuleit, J. Knop, 1998, Journal of immunology.

Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity

A. Gambotto, T. Tüting, J. Steitz, 2002, Gene Therapy.

Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins

T. Tüting, K. Steinbrink, H. Jonuleit, 2000, Archives of Dermatological Research.

Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes.

A. Enk, H. Okamura, T. Tanimoto, 1997, Journal of immunology.

Different cellular reaction patterns of epidermal Langerhans cells after application of contact sensitizing, toxic, and tolerogenic compounds. A comparative ultrastructural and morphometric time-course analysis.

G. Kolde, J. Knop, J. Knop, 1987, The Journal of investigative dermatology.

Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors.

I. Bellinghausen, J. Saloga, J. Knop, 2000, The Journal of allergy and clinical immunology.

Allergen-specific immune deviation from a TH2 to a TH1 response induced by dendritic cells and collagen type I.

A. Enk, I. Bellinghausen, J. Saloga, 1999, The Journal of allergy and clinical immunology.

IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo.

A. Enk, G. Schuler, T. Germann, 1995, Journal of immunology.

Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin‐12 treatment in vivo

I. Bellinghausen, J. Saloga, Enk, 1998, Immunology.